Profile data is unavailable for this security.
About the company
Venus Medtech Hangzhou Inc is a China-based company principally engaged in the research and development, and the manufacture and sale of bioprosthetic heart valves. The Company mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The Company mainly conducts its businesses in the domestic market and overseas markets.
- Revenue in HKD (TTM)483.90m
- Net income in HKD-727.79m
- Incorporated2009
- Employees605.00
- LocationVenus Medtech Hangzhou IncRoom 311, 3/F, Block 2, No. 88Jiangling Road, Binjiang DistrictHANGZHOU ChinaCHN
- Websitehttps://www.venusmedtech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vincent Medical Holdings Ltd | 869.70m | 87.51m | 665.86m | 1.46k | 7.43 | 1.06 | 5.14 | 0.7656 | 0.136 | 0.136 | 1.35 | 0.9542 | 0.9226 | 3.30 | 3.96 | 654,893.10 | 9.72 | 10.32 | 13.97 | 14.95 | 34.47 | 34.77 | 10.53 | 10.25 | 1.55 | -- | 0.2049 | 37.10 | 11.56 | 9.79 | 20.76 | 43.10 | 26.32 | 24.57 |
| BioSino Bio-technology and Science Inc | 254.90m | -53.60m | 732.22m | 471.00 | -- | 4.31 | -- | 2.87 | -0.3704 | -0.3704 | 1.76 | 1.17 | 0.4633 | 2.41 | 1.59 | 510,813.80 | -12.66 | -2.01 | -33.54 | -5.46 | 38.77 | 39.79 | -27.32 | -3.72 | 0.7174 | -5.03 | 0.477 | -- | -9.00 | -7.92 | -265.14 | -- | -3.59 | -- |
| China Health Group Ltd | 39.87m | -60.77m | 816.87m | 127.00 | -- | -- | -- | 20.49 | -0.1034 | -0.1034 | 0.0722 | -0.0363 | 0.2052 | 2.02 | 1.76 | 269,412.20 | -31.41 | -16.08 | -261.02 | -42.30 | 22.79 | 28.29 | -153.08 | -44.72 | 0.7455 | -22.53 | -- | -- | -35.02 | -2.92 | -68.69 | -- | 30.06 | -- |
| Broncus Holding Corp | 47.51m | -118.43m | 896.03m | 193.00 | -- | 0.7139 | -- | 18.86 | -0.2441 | -0.2441 | 0.0979 | 2.38 | 0.0347 | 0.4314 | 0.855 | 237,567.30 | -8.65 | -44.03 | -8.96 | -46.77 | 72.36 | 76.11 | -249.25 | -849.59 | 26.33 | -- | 0.0003 | -- | -20.71 | 0.1458 | 45.52 | -- | -2.79 | -- |
| Kaisa Health Group Holdings Ltd | 166.42m | -31.22m | 1.00bn | 917.00 | -- | 2.30 | -- | 6.03 | -0.0062 | -0.0062 | 0.033 | 0.0865 | 0.308 | 6.69 | 1.52 | 193,284.50 | -6.59 | -7.25 | -7.83 | -9.34 | 41.58 | 45.27 | -21.40 | -28.20 | 3.89 | -- | 0.0257 | -- | -0.2824 | -5.93 | -720.72 | -- | -19.69 | -- |
| Gaush Meditech Ltd | 1.63bn | 115.40m | 1.05bn | 819.00 | 9.02 | 0.5461 | 5.06 | 0.6422 | 0.7848 | 0.7848 | 11.10 | 12.96 | 0.535 | 2.08 | 9.05 | 1,844,230.00 | 3.62 | -1.53 | 4.67 | -2.20 | 47.29 | 47.66 | 6.77 | -2.90 | 1.57 | 8.16 | 0.2188 | -- | 1.58 | 5.24 | -46.75 | -- | 79.78 | -- |
| Venus MedTech HangZhou Inc | 483.90m | -727.79m | 1.24bn | 605.00 | -- | 0.5314 | -- | 2.57 | -1.66 | -1.66 | 1.11 | 5.31 | 0.1218 | 0.9065 | 2.08 | 700,287.80 | -18.34 | -13.83 | -21.01 | -15.57 | 75.83 | 78.74 | -150.57 | -151.55 | 1.56 | -32.63 | 0.1928 | -- | -4.18 | 15.08 | -1.50 | -- | 11.12 | -- |
| Beijing Airdoc Technology Co Ltd | 165.78m | -200.05m | 1.30bn | 193.00 | -- | 0.9099 | -- | 7.83 | -1.96 | -1.96 | 1.63 | 13.91 | 0.1002 | 1.57 | 2.80 | 587,862.10 | -12.54 | -12.40 | -13.31 | -13.54 | 66.29 | 56.72 | -125.12 | -128.07 | 8.71 | -- | 0.0098 | -- | -23.34 | 38.74 | -92.75 | -- | 1.28 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 23.63m | -101.17m | 1.37bn | 70.00 | -- | 2.53 | -- | 57.90 | -0.4156 | -0.4156 | 0.0971 | 2.22 | 0.0251 | 0.8435 | 3.43 | 375,048.90 | -11.04 | -30.86 | -12.96 | -32.99 | 46.47 | -- | -439.71 | -- | 11.95 | -1.47 | 0.203 | -- | -- | -- | 50.00 | -- | 25.75 | -- |
| Cryofocus Medtech (Shanghai) Co Ltd | 96.45m | -86.09m | 1.45bn | 180.00 | -- | 21.73 | -- | 15.02 | -0.36 | -0.36 | 0.4034 | 0.2725 | 0.4945 | 1.12 | -- | 349,469.50 | -47.93 | -- | -72.64 | -- | 67.45 | -- | -96.93 | -- | 1.40 | -54.78 | 0.3918 | -- | 30.72 | -- | -7.06 | -- | -- | -- |
| Shanghai HeartCare Medcl Tech Corp Ltd | 379.35m | 48.06m | 1.76bn | 327.00 | 37.39 | 1.43 | 21.37 | 4.63 | 1.24 | 1.24 | 9.94 | 32.51 | 0.2736 | 0.7131 | 3.54 | 1,102,750.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Guanze Medical Infrm Indstry (Hldng) Ltd | 167.13m | 23.48m | 1.85bn | 58.00 | 79.20 | 6.21 | 56.45 | 11.08 | 0.0246 | 0.0246 | 0.1766 | 0.3139 | 0.5073 | 2.21 | 1.30 | 2,932,115.00 | 7.23 | 9.50 | 8.33 | 12.04 | 36.79 | 41.43 | 14.25 | 13.09 | 5.23 | 51.53 | 0.0544 | 34.79 | -0.2127 | 2.03 | -37.59 | -5.08 | 24.24 | -- |
| Ethk Labs Inc | 3.49bn | 197.35m | 1.86bn | 877.00 | 9.61 | 0.479 | 7.65 | 0.5337 | 0.1207 | 0.1207 | 2.14 | 2.42 | 0.536 | 1.06 | 6.84 | 4,040,234.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
Data as of Feb 16 2026. Currency figures normalised to Venus Medtech Hangzhou Inc's reporting currency: Hong Kong Dollar HKD
0.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SEI Investments Canada Co.as of 30 Jun 2025 | 914.50k | 0.21% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 506.50k | 0.12% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 130.00k | 0.03% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 89.71k | 0.02% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 46.50k | 0.01% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 4.50k | 0.00% |
| DFA Australia Ltd.as of 30 Nov 2025 | 704.00 | 0.00% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 196.00 | 0.00% |
| Shanxi Securities Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 0.00 | 0.00% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
